Boston Scientific Corp's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Begin-Period-Cashflow" stands at 4.92 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 06/30/2024.
Boston Scientific Corp's third quarter result of 0.741 Billion USD for the item "Begin Period Cashflow" represents a decrease of -19.37 percent compared to it's second quarter result.
Also, Boston Scientific Corp's third quarter result of 0.741 Billion USD for the item "Begin Period Cashflow" represents a decrease of -75.80 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Boston Scientific Corp's third quarter result of 4.92 Billion USD for the item "Begin Period Cashflow" represents a decrease of -32.08 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -35.93 percent compared to the value the year prior.
The 1 year change in percent is -35.93.
The 3 year change in percent is -5.59.
The 5 year change in percent is 22.91.
The 10 year change in percent is 148.48.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Abbott Laboratories - Begin Period Cashflow | 217,696,616,448.00 |
![]() | Intuitive Surgical Inc - Begin Period Cashflow | 206,245,888,000.00 |
![]() | EssilorLuxottica S. A. - Begin Period Cashflow | 172,241,486,586.05 |
![]() | Danaher Corporation - Begin Period Cashflow | 162,006,663,168.00 |
![]() | Stryker Corporation - Begin Period Cashflow | 139,209,850,880.00 |